Clinical effect of cardiac shock wave therapy on patients with ischaemic heart disease: A systematic review and meta-analysis

European Journal of Clinical Investigation

Volumn 45, Issue 12, 2015, Pages 1270-1285

  Wang, Jing ^a,b   Zhou, Chao ^a,b   Liu, Lin ^b   Pan, Xizhuo ^a,b   Guo, Tao ^a,b  

^a Health Education Institute   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Angina pectoris; Cardiac shock wave; Ischaemic heart disease

Indexed keywords

GLYCERYL TRINITRATE; VASODILATOR AGENT;

ANGINA PECTORIS; ARTICLE; CARDIAC IMAGING; CARDIAC SHOCK WAVE THERAPY; CARDIOVASCULAR DISEASE ASSESSMENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; ECHOCARDIOGRAPHY; EXTRACORPOREAL LITHOTRIPSY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; WALKING; AGED; CLINICAL TRIAL (TOPIC); FEMALE; HIGH-ENERGY SHOCK WAVE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBSERVATIONAL STUDY; THERAPEUTIC USE; TREATMENT OUTCOME;

AGED; CLINICAL TRIALS AS TOPIC; FEMALE; HIGH-ENERGY SHOCK WAVES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITROGLYCERIN; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84983133221     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12546     Document Type: Article

References (43)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association. Circulation 2015;131:e29-322.
2. Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619.
3. Simoons ML, Windecker S. Controversies in cardiovascular medicine: chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J 2010;31:530-41.
4. Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy for ischemic cardiovascular disorders. Am J Cardiovasc Drugs 2011;11:295-302.
5. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006;114:2823-30.
6. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94.
7. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
8. Wang Y, Guo T, Ma TK, Cai HY, Tao SM, Peng YZ et al. A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease. Cardiovasc Ultrasound 2012;10:35.
9. Yang P, Guo T, Wang W, Peng YZ, Wang Y, Zhou P et al. Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease. Heart Vessels 2013;28:284-91.
10. Peng YZ, Guo T, Yang P, Yang HW, Zhou P, Wang Y et al. [Effects of extracorporeal cardiac shock wave therapy in patients with ischemic heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi 2012;40:141-6.
11. Wang Y, Guo T, Cai HY, Ma TK, Tao SM, Sun S et al. Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease. Clin Cardiol 2010;33:693-9.
12. Higgins JP, Green s. Cochrane Handbook for Systematic Reviews of Interventions; 2014; http://handbook.cochrane.org.
13. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
15. da Costa BR, Juni P. Systematic reviews and meta-analyses of randomized trials: principles and pitfalls. Eur Heart J 2014;35:3336-45.
16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
18. Faber L, Lindner O, Prinz C, Fricke E, Hering D, Burchert W et al. Echo-guided extracorporeal shock wave therapy for refractory angina improves regional myocardial blood flow as assessed by PET imaging. J Am Coll Cardiol 2010;55:A120-E1125.
19. Ping Y, Yunzhu P, Tao G, Yu W, Ping Z, Hongyan C et al. [A clinical study of extracorporeal cardiac shock wave treatment for patients with coronary heart disease]. Chongqing yi xue za zhi 2012;41:847-51.
20. Zhou T, Zhigang G, Shanguo Z. [The effect of cardiac shock wave therapy in patients with ischemic heart failure]. World Health Digest Medical Periodieal 2013;10:114-5.
21. Alunni G, Marra S, Meynet I, D'Amico M, Elisa P, Fanelli A et al. The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina. Cardiovasc Revasc Med 2015;16:6-11.
22. Khattab AA, Brodersen B, Schuermann-Kuchenbrandt D, Beurich H, Tolg R, Geist V et al. Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. Int J Cardiol 2007;121:84-5.
23. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006;17:63-70.
24. Vasyuk YA, Hadzegova AB, Shkolnik EL, Kopeleva MV, Krikunova OV, Iouchtchouk EN et al. Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. Congest Heart Fail 2010;16:226-30.
25. Zuoziene G, Laucevicius A, Leibowitz D. Extracorporeal shockwave myocardial revascularization improves clinical symptoms and left ventricular function in patients with refractory angina. Coron Artery Dis 2012;23:62-7.
26. Wang Y, Guo T, Cai HY, Ma TK, Tao SM, Chen MQ et al. [Extracorporeal cardiac shock wave therapy for treatment of coronary artery disease]. Zhonghua Xin Xue Guan Bing Za Zhi 2010;38:711-5.
27. Kazmi WH, Rasheed SZ, Ahmed S, Saadat M, Altaf S, Samad A. Noninvasive therapy for the management of patients with advanced coronary artery disease. Coron Artery Dis 2012;23:549-54.
28. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004;110:3055-61.
29. Fu M, Sun CK, Lin YC, Wang CJ, Wu CJ, Ko SF et al. Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment. PLoS One 2011;6:e24342.
30. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 2007;18:397-404.
31. Cassar A, Prasad M, Rodriguez-Porcel M, Reeder GS, Karia D, DeMaria AN et al. Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris. Mayo Clin Proc 2014;89:346-54.
32. Mariotto S, de Prati AC, Cavalieri E, Amelio E, Marlinghaus E, Suzuki H. Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action. Curr Med Chem 2009;16:2366-72.
33. Wang FS, Wang CJ, Huang HJ, Chung H, Chen RF, Yang KD. Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells. Biochem Biophys Res Commun 2001;287:648-55.
34. Yip HK, Chang LT, Sun CK, Youssef AA, Sheu JJ, Wang CJ. Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J 2008;72:150-6.
35. Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes 2014;7:640-7.
36. Assmus B, Walter DH, Seeger FH, Leistner DM, Steiner J, Ziegler I et al. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA 2013;309:1622-31.
37. Wu G, Sanderson B, Bittner V. The 6-minute walk test: how important is the learning effect? Am Heart J 2003;146:129-33.
38. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-14.
39. Ammirati E, Rimoldi OE, Camici PG. Myocardial viability in ischemic left ventricular dysfunction. N Engl J Med 2011;365:471; author reply 2-3.
40. Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 2002;31:115-23.
41. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
42. Farkouh ME, Fuster V. Meta-analysis of small trials: proceed with caution. Nat Clin Pract Cardiovasc Med 2007;4:635.
43. Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med 2013;173:611-2.